Citations

Showing 10 of 108094 citations.

Initial Experience of Tomosynthesis-Guided Vacuum-Assisted Biopsies of Tomosynthesis-Detected (2D Mammography and Ultrasound Occult) Architectural Distortions
Patel, Bhavika , Pizzitola, Victor J. , Lorans, Roxanne, Giurescu, Marina E., Eversman, William G. , Lewin, John, Covington, Matthew, Giurescu, Marina, Eversman, William, Patel, Bhavika K , Covington, Matthew F.

Mayo Clinic

American Journal of Roentgenology | March 23, 2018 | Volume: 210 | Issue: 6 | Pages: 1395-1400

10.2214/ajr.17.18802 | PMID 29570367 Get It

Appropriate Objective Functions for Quantifying Iris Mechanical Properties Using Inverse Finite Element Modeling
Pant, Anup , Dorairaj, Syril K., Amini, Rouzbeh , Dorairaj, Syril

Mayo Clinic

Journal of Biomechanical Engineering | March 23, 2018 | Volume: 140 | Issue: 7 | Pages: No page available

10.1115/1.4039679 | PMID 29570756 Get It

Quantifying the mechanical properties of the iris is important, as it provides insight into the pathophysiology of glaucoma. Recent ex vivo studies have shown that the mechanical properties of the iris are different in glaucomatous eyes as compared to normal ones. Notwithstanding the importance of the ex vivo studies, such measurements are severely limited for diagnosis and preclude development of treatment strategies. With the advent of detailed imaging modalities, it is possible to determine the in vivo mechanical properties using inverse finite element (FE) modeling. An inverse modeling approach requires an appropriate objective function for reliable estimation of parameters. In the case of the iris, numerous measurements such as iris chord length (CL) and iris concavity (CV) are made routinely in clinical practice. In this study, we have evaluated five different objective functions chosen based on the iris biometrics (in the presence and absence of clinical measurement errors) to determine the appropriate criterion for inverse modeling. Our results showed that in the absence of experimental measurement error, a combination of iris CL and CV can be used as the objective function. However, with the addition of measurement errors, the objective functions that employ a large number of local displacement values provide more reliable outcomes.
Pharmacy informatics in multihospital health systems: Opportunities and challenges
Chalmers, Jeffrey, Siska, Mark H., Le, Trinh, Knoer, Scott J., Siska, Mark

Mayo Clinic

American Journal of Health-System Pharmacy | March 23, 2018 | Volume: 75 | Issue: 7 | Pages: 457-464

10.2146/ajhp170580 | PMID 29572314 Get It

Ranking of the most effective treatments for cardiovascular disease using SUCRA: Is it as sweet as it appears?
Carter, Rickey E. , Carter, Rickey E , Wang, Zhen

Mayo Clinic

European Journal of Preventive Cardiology | March 23, 2018 | Volume: 25 | Issue: 8 | Pages: 842-843

10.1177/2047487318767199 | PMID 29569939 Get It

mHealth and cardiovascular diseases self-management: There is still a long way ahead of us
Supervía, Marta , Lopez‐Jimenez, Francisco, López-Jiménez, Francisco

Mayo Clinic

European Journal of Preventive Cardiology | March 23, 2018 | Volume: 25 | Issue: 9 | Pages: 974-975

10.1177/2047487318766644 | PMID 29569940 Get It

Consequences of B-Cell-Depleting Therapy: Hypogammaglobulinemia and Impaired B-Cell Reconstitution
Sacco, Keith , Abraham, Roshini S. , Sacco, Keith A

Mayo Clinic

Immunotherapy | March 23, 2018 | Volume: 10 | Issue: 8 | Pages: 713-728

10.2217/imt-2017-0178 | PMID 29569510 Get It

Demographics and clinical characteristics of episodic hypothermia in multiple sclerosis
Toledano, Michel , Weinshenker, Brian G. , Parisi, Joseph E. , Soldán, M. Mateo Paz , Weinshenker, Brian G , Kaufmann, Timothy J. , Paz Soldán, M Mateo

Mayo Clinic

Multiple Sclerosis Journal | March 23, 2018 | Volume: 25 | Issue: 5 | Pages: 709-714

10.1177/1352458518767045 | PMID 29570004 Get It

Background: Episodic hypothermia (EH) can occur in multiple sclerosis (MS). The putative mechanism is impairment of thermoregulation due to a presumed demyelinating hypothalamic lesion. Objective: To describe a cohort of patients with MS, who developed EH. Methods: Patients were identified through review of the Mayo Clinic electronic medical record (1996 to July 2015). Search terms were [multiple sclerosis] or [MS] within the diagnoses field and [hypothermia] within any field. We reviewed records for accuracy of diagnoses and abstracted relevant data. Magnetic resonance imaging (MRI) was reviewed for presence of hypothalamic lesions. Results: Of 156 patients, 34 had concurrent MS and hypothermia. Thirty-two (94%) had progressive disease at EH onset. Median MS duration was 19.9 years, and median expanded disability status scale (EDSS) was 8.0. Most patients presented with alterations in consciousness. Infection was suspected as the precipitating factor in 19 (56%), but clinically/laboratory supported in only 9 (28%). MRI lesions were evident within the hypothalamus in only 4 (14%). Conclusion: EH occurs predominantly in patients with advanced secondary progressive MS. The major manifestation is altered consciousness. Infection is often suspected as causal, but infrequently confirmed. Although commonly implicated, hypothalamic lesions were rarely evident on MRI and were absent in two post-mortem evaluations.
Combined Pathologies in FTLD-TDP Types A and C
Gefen, Tamar , Mao, Qinwen , Kım, Garam , Seçkin, Mustafa , Bonakdarpour, Borna , Ramos, Eliana Marisa , Coppola, Giovanni , Rademakers, Rosa , Rogalskı, Emily , Rademaker, Alfred , Weıntraub, Sandra , Geula, Changiz , Bigio, Eileen H. , Ahmadian, Saman Seyed , Mesulam, Marsel M. , Mao, Qinwen

Mayo Clinic

Journal of Neuropathology & Experimental Neurology | March 23, 2018 | Volume: 77 | Issue: 5 | Pages: 405-412

10.1093/jnen/nly018 | PMID 29584904 Get It

A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes
Talluri, Swapna, Riaz, Haris, Rahman, Hammad , Nasir, Fahad, Riaz, Irbaz Bin , Sattur, Sudhakar, Ahmed, Haitham , Bin Riaz, Irbaz, Riaz, Irbaz B , Khan, Safi U. , Kaluski, Edo , Krasuski, Richard A.

Mayo Clinic

European Journal of Preventive Cardiology | March 23, 2018 | Volume: 25 | Issue: 8 | Pages: 844-853

10.1177/2047487318766612 | PMID 29569492 Get It

Background The comparative effects of statins, ezetimibe with or without statins and proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors remain unassessed. Design Bayesian network meta-analysis was conducted to compare treatment groups. Methods Thirty-nine randomized controlled trials were selected using MEDLINE, EMBASE, and CENTRAL (inception – September 2017). Results In network meta-analysis of 189,116 patients, PCSK9 inhibitors were ranked as the best treatment for prevention of major adverse cardiovascular events (Surface Under Cumulative Ranking Curve (SUCRA), 85%), myocardial infarction (SUCRA, 84%) and stroke (SUCRA, 80%). PCSK9 inhibitors reduced the risk of major adverse cardiovascular events compared with ezetimibe + statin (odds ratio (OR): 0.72; 95% credible interval (CrI), 0.55–0.95; Grading of Recommendation Assessment, Development and Evaluation (GRADE) criteria: moderate), statin (OR: 0.78; 95% CrI: 0.62–0.97; GRADE: moderate) and placebo (OR: 0.63; 95% CrI: 0.49–0.79; GRADE: high). The PCSK9 inhibitors were consistently superior to groups for major adverse cardiovascular event reduction in secondary prevention trials (SUCRA, 95%). Statins had the highest probability of having lowest rates of all-cause mortality (SUCRA, 82%) and cardiovascular mortality (SUCRA, 84%). Compared with placebo, statins reduced the risk of all-cause mortality (OR: 0.88; 95% CrI: 0.83–0.94; GRADE: moderate) and cardiovascular mortality (OR: 0.84; 95% CrI: 0.77–0.90; GRADE: high). For cardiovascular mortality, PCSK9 inhibitors were ranked as the second best treatment (SUCRA, 78%) followed by ezetimibe + statin (SUCRA, 50%). Conclusion PCSK9 inhibitors were ranked as the most effective treatment for reducing major adverse cardiovascular events, myocardial infarction and stroke, without having major safety concerns. Statins were ranked as the most effective therapy for reducing mortality.
Faculty Opinions recommendation of Abnormal beta power is a hallmark of explicit movement control in functional movement disorders.
Caviness, John N.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 23, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.732345653.793543813 Get It